Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Glavni autor: | Tania, Umme |
---|---|
Daljnji autori: | Haque , Md. Aminul |
Format: | Disertacija |
Jezik: | en_US |
Izdano: |
Brac University
2021
|
Teme: | |
Online pristup: | http://hdl.handle.net/10361/15111 |
Similar Items
-
Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Izdano: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
od: Tabassum, Turana
Izdano: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
od: Sagar, Baejid Hossain
Izdano: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
od: Fred, Namanda Rogers
Izdano: (2021)